Quantification of hormone-induced atrophy of large myotubes from C 2C12 and L6 cells: Atrophy-inducible and atrophy-resistant C2C12 myotubes

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 2, 2006, Pages

  Sultan, Karim R ^a,b   Henkel, Birgit ^b   Terlou, Maarten ^a   Haagsman, Henk P ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Atrogin; Glucocorticoids; Nuclear receptors

Indexed keywords

CURCUMIN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; LIOTHYRONINE; LIOTHYRONINE RECEPTOR; MESSENGER RNA; ULTROSER G; GLUCOCORTICOID; ISOPROTEIN; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL COMPOSITION; CATABOLISM; CONTROLLED STUDY; GENE EXPRESSION; HORSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; MUSCLE ATROPHY; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; ATROPHY; CELL LINE; CELL SHAPE; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; METABOLISM; MUSCLE CELL; PATHOLOGY;

ANIMALIA; EQUUS CABALLUS;

ANIMALS; ATROPHY; CELL LINE; CELL SHAPE; CULTURE MEDIA; GLUCOCORTICOIDS; MICE; MUSCLE FIBERS; PROTEIN ISOFORMS; RATS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, THYROID HORMONE; RNA, MESSENGER; TRIIODOTHYRONINE;

EID: 33644849468     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00163.2005     Document Type: Article

References (40)

1. Angeras U and Hasselgren PO. Protein degradation in skeletal muscle during experimental hyperthyroidism in rats and the effect of betablocking agents. Endocrinology 120: 1417-1421, 1987.
2. Auclair D, Garrel DR, Chaouki Zerouala A, and Ferland LH. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Am J Physiol Cell Physiol 272: C1007-C1016, 1997.
3. Benders AA, van Kuppevelt TH, Oosterhof A, and Veerkamp JH. The biochemical and structural maturation of human skeletal muscle cells in culture: the effect of the serum substitute Ultroser G. Exp Cell Res 195: 284-294, 1991.
4. Carter WJ, van der Weijden Benjamin WS, and Faas FH. Effect of experimental hyperthyroidism on skeletal-muscle proteolysis. Biochem J 194: 685-690, 1981.
5. Clement K, Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, Storey JD, Brown PO, Barsh GS, and Langin D. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Res 12: 281-291, 2002.
6. Dehoux M, Van Beneden R, Pasko N, Lause P, Verniers J, Underwood L, Ketelslegers JM, and Thissen JP. Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes. Endocrinology 145: 4806-4812, 2004.
7. DeMartino GN and Goldberg AL. Thyroid hormones control lysosomal enzyme activities in liver and skeletal muscle. Proc Natl Acad Sci USA 75: 1369-1373, 1978.
8. Diekman MJ, Zandieh Doulabi B, Platvoet-Ter Schiphorst M, Fliers E, Bakker O, and Wiersinga WM. The biological relevance of thyroid hormone receptors in immortalized human umbilical vein endothelial cells. J Endocrinol 168: 427-433, 2001.
9. Downes M, Griggs R, Atkins A, Olson EN, and Muscat GE. Identification of a thyroid hormone response element in the mouse myogenin gene: characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site. Cell Growth Differ 4: 901-909, 1993.
10. Gomes MD, Lecker SH, Jagoe RT, Navon A, and Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98: 14440-14445, 2001.
11. Hasselgren PO. Glucocorticoids and muscle catabolism. Curr Opin Clin Nutr Metab Care 2: 201-205, 1999.
12. Koenig RJ and Smith RJ. L6 cells as a tissue culture model for thyroid hormone effects on skeletal muscle metabolism. J Clin Invest 76: 878-881, 1985.
13. Komamura K, Shirotani-Ikejima H, Tatsumi R, Tsujita-Kuroda Y, Kitakaze M, Miyatake K, Sunagawa K, and Miyata T. Differential gene expression in the rat skeletal and heart muscle in glucocorticoid-induced myopathy: analysis by microarray. Cardiovasc Drugs Ther 17: 303-310, 2003.
14. Konagaya M, Konagaya Y, Friedman JA, and Max SR. Nuclear glucocorticoid receptor binding in L6 skeletal muscle cells in culture. J Steroid Biochem 29: 685-689, 1988.
15. Lawson MA and Purslow PP. Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cells Tissues Organs 167: 130-137, 2000.
16. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, and Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51, 2004.
17. Lin KH, Willingham MC, Liang CM, and Cheng SY. Intracellular distribution of the endogenous and transfected beta form of thyroid hormone nuclear receptor visualized by the use of domain-specific monoclonal antibodies. Endocrinology 128: 2601-2609, 1991.
18. Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, and Bhasin S. Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 281: E1128-E1136, 2001.
19. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J, and Salehian B. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285: E363-E371, 2003.
20. Morrison WL, Gibson JN, Jung RT, and Rennie MJ. Skeletal muscle and whole body protein turnover in thyroid disease. Eur J Clin Invest 18: 62-68, 1988.
21. Nagase I, Yoshida S, Canas X, Irie Y, Kimura K, Yoshida T, and Saito M. Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes. FEBS Lett 461: 319-322, 1999.
22. Portier GL, Benders AG, Oosterhof A, Veerkamp JH, and van Kuppevelt TH. Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium. In Vitro Cell Dev Biol Anim 35: 219-227, 1999.
23. Ramakers C, Ruijter JM, Deprez RH, and Moorman AF. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339: 62-66, 2003.
24. Rooyackers OE and Nair KS. Hormonal regulation of human muscle protein metabolism. Annu Rev Nutr 17: 457-485, 1997.
25. Rozen S and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology, edited by Krawetz S and Misener S. Totowa, NJ: Humana, 2000, p. 365-386.
26. Sacheck JM, Ohtsuka A, McLary SC, and Goldberg AL. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287: E591-E601, 2004.
27. Schuler MJ, Buhler S, and Pette D. Effects of contractile activity and hypothyroidism on nuclear hormone receptor mRNA isoforms in rat skeletal muscle. Eur J Biochem 264: 982-988, 1999.
28. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, and Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004.
29. Sultan KR, Dittrich BT, and Pette D. Calpain activity in fast, slow, transforming, and regenerating skeletal muscles of rat. Am J Physiol Cell Physiol 279: C639-C647, 2000.
30. Te Pas MF, de Jong PR, and Verburg FJ. Glucocorticoid inhibition of C2C12 proliferation rate and differentiation capacity in relation to mRNA levels of the MRF gene family. Mol Biol Rep 27: 87-98, 2000.
31. Thaloor D, Miller KJ, Gephart J, Mitchell PO, and Pavlath GK. Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol Cell Physiol 277: C320-C329, 1999.
32. 2+-ATPase gene. Biochem J 321: 845-848, 1997.
33. 2+-ATPase. Biochem J 329: 131-136, 1998.
34. 12 myotubes by dexamethasone: effect of the proteasome inhibitor MG-132. J Cell Physiol 181: 455-461, 1999.
35. 12 myocytes lack an insulin-responsive vesicular compartment despite dexamethasone-induced GLUT4 expression. Am J Physiol Endocrinol Metab 283: E514-E524, 2002.
36. Weber K, Bruck P, Mikes Z, Kupper JH, Klingenspor M, and Wiesner RJ. Glucocorticoid hormone stimulates mitochondrial biogenesis specifically in skeletal muscle. Endocrinology 143: 177-184, 2002.
37. Yaffe D. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci USA 61: 477-483, 1968.
38. Yaffe D and Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727, 1977.
39. 12 myoblasts depends on the expression of endogenous IGFs and not serum depletion. Am J Physiol Cell Physiol 283: C1278-C1286, 2002.
40. 2+-ATPase gene. J Biol Chem 269: 1460-1467, 1994.